Human dendritic cells induce tumor‐specific apoptosis by soluble factors
Open Access
- 25 September 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 102 (1) , 20-28
Abstract
Dendritic cells (DCs) are the most potent antigen producing cells (APCs) for initiation of immune responses including anti‐tumor immune responses. In previous reports, it has been shown that DCs efficiently take up and process apoptotic or necrotic bodies of tumor cells. It has also been shown that DCs pulsed with tumor cell apoptotic bodies, lysates or peptides generate potent anti‐tumor immune responses. Direct interactions between DCs and viable tumor cells, however, have not been clearly elucidated. We report that monocyte‐derived, CD1a+ immature DCs (iDCs) significantly inhibit the growth of breast tumor cells in coculture and transwell experiments in the presence of soluble CD40 ligand (sCD40L), LPS or both. The growth inhibition effects correlated with cell cycle arrest and apoptosis of breast tumor cells. The effects were associated with morphological changes of tumor cells from a round shape to a flat, spindle shape. In contrast, no inhibition of proliferation or morphological changes was observed on normal PBMC, K562 or breast fibroblasts. Interestingly, iDCs undergoing maturation induced by sCD40L+LPS induced a much stronger growth inhibitory effect than iDCs alone or mature DCs treated with sCD40L+LPS. Fractionation of supernatants showed the anti‐tumor effects were mediated by a TNF‐α‐dependent and ‐independent mechanism. Soluble FasL and TRAIL were not involved. Our findings suggest that maturing DCs have the intrinsic ability to induce cell‐cycle arrest and apoptosis of breast tumor cells through soluble factors, but not normal cells, in addition to their Ag presentation function.Keywords
This publication has 18 references indexed in Scilit:
- Tumoricidal Activity of Monocyte-Derived Dendritic Cells: Evidence for a Caspase-8-Dependent, Fas-Associated Death Domain-Independent MechanismThe Journal of Immunology, 2001
- Cytotoxic Activity of Human Dendritic Cells Is Differentially Regulated by Double-Stranded RNA and CD40 LigandThe Journal of Immunology, 2001
- Dendritic cells resurrect antigens from dead cellsTrends in Immunology, 2001
- Dendritic Cells Capture Killed Tumor Cells and Present Their Antigens to Elicit Tumor-Specific Immune ResponsesThe Journal of Immunology, 2000
- Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail)Journal of Experimental Medicine, 1999
- CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cellsProceedings of the National Academy of Sciences, 1999
- Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivoNature Medicine, 1999
- Generation of Tumor Immunity by Bone Marrow-Derived Dendritic Cells Correlates with Dendritic Cell Maturation StageThe Journal of Immunology, 1999
- Dendritic cells and the control of immunityNature, 1998
- Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.Journal of Experimental Medicine, 1996